4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0000890465-14-000036
CIK 0000890465operating
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:35 PM ET
Size
11.4 KB
Accession
0000890465-14-000036
Insider Transaction Report
Form 4
GRONINGER JAMES G
Director
Transactions
- Exercise/Conversion
Common Stock
2014-02-13+15,188→ 15,938 total - Sale
Common Stock
2014-02-13$37.70/sh−6,000$226,200→ 9,938 total - Award
Restricted Stock Units
2014-02-12+4,572→ 4,572 total→ Common Stock (4,572 underlying) - Exercise/Conversion
Restricted Stock Units
2014-02-13−15,188→ 0 totalExercise: $0.00→ Common Stock (15,188 underlying)
Footnotes (5)
- [F1]Each vested Restricted Stock Unit was the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2013.
- [F3]Each Restricted Stock Unit was awarded under the Issuer's amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock.
- [F4]One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.
- [F5]On February 13, 2013, the Restricted Stock Units were granted with one hundred percent of such Restricted Stock Units vesting on the first anniversary of the date of grant. As of the date of this filing, all of the Restricted Stock Units have vested.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:35 PM ET
- Size
- 11.4 KB